Enhanced protection from renal ischemia: Reperfusion injury with A2A-adenosine receptor activation and PDE 4 inhibition
- 1 June 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59 (6), 2114-2125
- https://doi.org/10.1046/j.1523-1755.2001.00726.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Neutrophil A2AAdenosine Receptor Inhibits Inflammation in a Rat Model of Meningitis: Synergy with the Type IV Phosphodiesterase Inhibitor, RolipramThe Journal of Infectious Diseases, 1999
- Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.Journal of Clinical Investigation, 1996
- Adenosine modulates vasomotor tone in outer medullary descending vasa recta of the rat.Journal of Clinical Investigation, 1996
- Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury.Journal of Clinical Investigation, 1996
- The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-α-primed neutrophil oxidative activityInternational Journal of Immunopharmacology, 1995
- Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.Journal of Clinical Investigation, 1987
- Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.Journal of Clinical Investigation, 1986
- Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.The Journal of Experimental Medicine, 1983
- Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme MarkerJournal of Investigative Dermatology, 1982
- The extinction coefficient of cytochrome cBiochimica et Biophysica Acta, 1962